Acquisition by Van Nostrand Robert L of 1567 shares of Intracellular subject to Rule 16b-3

ITCI Stock  USD 128.25  0.21  0.16%   
Under 54% of Intracellular's traders are presently thinking to get in. The analysis of overall sentiment of trading Intracellular Th stock suggests that some investors are interested at this time. Intracellular's investing sentiment shows overall attitude of investors towards Intracellular Th.
  
Filed transaction by Intracellular Th Director. Grant, award or other acquisition pursuant to Rule 16b-3

Read at macroaxis.com
Intracellular insider trading alert for acquisition of common stock by Van Nostrand Robert L, Director, on 17th of November 2024. This event was filed by Intracellular Th with SEC on 2024-06-23. Statement of changes in beneficial ownership - SEC Form 4

Cash Flow Correlation

Intracellular's cash-flow correlation analysis can be used to evaluate the unsystematic risk during the given period. It also helps investors identify the Intracellular's relationships between the major components of the statement of changes in financial position and other commonly used cash-related accounts. When such correlations are discovered, they may help managers and analysts to enhance performance or determine appealing investment opportunities.
Click cells to compare fundamentals

Intracellular Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Intracellular can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
60.1%
57.5%
46.6%
50.2%
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Intracellular Th Historical Investor Sentiment

Investor biases related to Intracellular's public news can be used to forecast risks associated with an investment in Intracellular. The trend in average sentiment can be used to explain how an investor holding Intracellular can time the market purely based on public headlines and social activities around Intracellular Th. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
News FrequencyInvestor Sentiment
Intracellular's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Intracellular and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Intracellular news discussions. The higher the estimate score, the more favorable the investor's outlook on Intracellular.

Intracellular Maximum Pain Price Across May 16th 2025 Option Contracts

Intracellular's options can also be used to analyze investors' bias and current market sentiment in the context of behavioral finance. For example, Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of Intracellular close to the expiration of its current option contract to expire worthlessly. According to most research, about 35% of options are not executed, with roughly 50% traded out before expiration. So, Max pain occurs when market makers reach a net favorable position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthlessly. Please continue to view the detailed analysis of Intracellular's options.
Calls PricePuts Price

Intracellular Fundamental Analysis

We analyze Intracellular's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Intracellular using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Intracellular based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Earnings Per Share

Earnings Per Share Comparative Analysis

Intracellular is currently under evaluation in earnings per share category among its peers. Earnings per Share (EPS) denotes the portion of a company's earnings that is allocated to each share of common stock. To calculate Earnings per Share investors will need to take a company's net income, subtract any dividends for preferred stock, and divide it by the number of average outstanding shares. EPS is usually presented in two different ways: basic and diluted. Fully diluted Earnings per Share takes into account effects of warrants, options, and convertible securities and is generally viewed by analysts as a more accurate measure.

Intracellular Th Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Intracellular stock to make a market-neutral strategy. Peer analysis of Intracellular could also be used in its relative valuation, which is a method of valuing Intracellular by comparing valuation metrics with similar companies.

Peers

Intracellular Related Equities

CYTHCyclo Therapeutics   1.32   
0%
25.0%
AMPHAmphastar   0.90   
0%
17.0%
COLLCollegium Pharmaceutical   0.25   
0%
4.0%
NBIXNeurocrine Biosciences   0.07   
1.0%
0%
PCRXPacira BioSciences,   0.39   
7.0%
0%
AMRXAmneal Pharmaceuticals,   0.59   
11.0%
0%
ANIPANI Pharmaceuticals   0.78   
14.0%
0%
DVAXDynavax Technologies   0.80   
15.0%
0%
AQSTAquestive Therapeutics   1.09   
20.0%
0%
ALKSAlkermes Plc   2.18   
41.0%
0%
IRWDIronwood Pharmaceuticals   5.26   
100.0%
0%

Complementary Tools for Intracellular Stock analysis

When running Intracellular's price analysis, check to measure Intracellular's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Intracellular is operating at the current time. Most of Intracellular's value examination focuses on studying past and present price action to predict the probability of Intracellular's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Intracellular's price. Additionally, you may evaluate how the addition of Intracellular to your portfolios can decrease your overall portfolio volatility.
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Fundamental Analysis
View fundamental data based on most recent published financial statements
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk